Carmell Co. (NASDAQ:CTCX – Get Free Report) was the target of a large increase in short interest during the month of October. As of October 31st, there was short interest totalling 505,100 shares, an increase of 29.1% from the October 15th total of 391,200 shares. Currently, 3.8% of the shares of the company are sold short. Based on an average daily trading volume, of 4,600,000 shares, the short-interest ratio is currently 0.1 days.
Carmell Price Performance
Carmell stock opened at $0.23 on Friday. Carmell has a twelve month low of $0.20 and a twelve month high of $4.31. The company’s 50-day moving average price is $0.38 and its two-hundred day moving average price is $1.14.
Carmell (NASDAQ:CTCX – Get Free Report) last released its quarterly earnings results on Wednesday, August 14th. The company reported ($0.16) earnings per share for the quarter. The company had revenue of $0.01 million during the quarter.
Institutional Inflows and Outflows
Carmell Company Profile
Carmell Corporation operates as a bio-aesthetics company. The company utilizes Carmell Secretome to support skin and hair health. Its Carmell Secretome consists of growth factors and proteins extracted from allogeneic human platelets sourced from tissue banks. The company also developed a microemulsion formulation that enables delivery of lipophilic and hydrophilic ingredients without relying on the Foul Fourteen, 14 potentially harmful excipients that are commonly used by other companies to impart texture, stability, and other desirable physicochemical attributes to cosmetic products.
Featured Stories
- Five stocks we like better than Carmell
- The How And Why of Investing in Oil Stocks
- ORIC: Working with Two Pharma Giants, Analysts See +100% Upside
- 3 Grocery Stocks That Are Proving They Are Still Essential
- Freeport-McMoRan, Copper Demand Short-Term Pain, Long-Term Gain
- Why is the Ex-Dividend Date Significant to Investors?
- Time to Load Up on Home Builders?
Receive News & Ratings for Carmell Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Carmell and related companies with MarketBeat.com's FREE daily email newsletter.